Factors associated with survival of Iranian patients with COVID-19: comparison of Cox regression and mixture cure model

Abstract

Backgrounds SARS-CoV-2 is almost the most problematic virus of this century. It has caused extensive damage to various economic, social, and health aspects worldwide. Nowadays, coronavirus disease 2019 (COVID-19) is the most dangerous threat to human survival. Therefore, this study aimed to investigate factors associated with the survival of Iranian patients with SARS-CoV-2. Methods This retrospective hospital-based cohort study was conducted on 870 COVID-19 patients with blood oxygen levels of less than 93%. Cox regression and mixture cure model were used and compared to analyze the patients’ survival. It is worth noting that no similar study has been previously conducted using mixture cure regression to model the survival of Iranian patients with COVID-19. Result The cure rate and median survival time were respectively 81.5% and 20 days. Cox regression identified that respiratory distress, history of heart disease and hypertension, and older age were shown to increase the hazard. The Incidence and Latency parts of the mixture cure model respectively revealed that respiratory distress, history of hypertension, diabetes and cardiovascular diseases (CVDs), cough, fever, and older age reduced the cure odds; also, respiratory distress, history of hypertension, and CVDs, and older age increased the hazard. Conclusion The findings of our study revealed that priority should be given to older patients with a history of diabetes, hypertension, and CVDs in receiving intensive care and immunization. Also, the lower cure odds for patients with respiratory distress, fever, and cough favor early hospitalization before the appearance of severe symptoms.

Analysis of Survival of Patients Hospitalized with COVID-19 in Espírito Santo, Brazil

“…A large number of patients have cardiovascular disease as a comorbidity or develop cardiovascular dysfunction during the pathological process after SARS-CoV-2 infection [ 24 ]. The findings of the current study showed that chronic cardiovascular disease, including hypertension, is a factor associated with a higher risk for death and a shorter survival among hospitalized patients, thus corroborating the literature [ 25 ]. The impact of COVID-19 on the cardiovascular system is worth noting, as individuals with pre-existing disease are among the most affected by the disease and have a more severe clinical course [ 24 , 25 , 26 , 27 , 28 , 29 , 30 ].…”

Risk Factors Associated with Severity and Death from COVID-19 in Iran: A Systematic Review and Meta-Analysis Study

“…After deleting duplicates, we identified 2463 studies from four databases and then screened articles by title and full text according to the study's objectives. Finally, 69 studies were included in the meta-analysis (Figure 1), of which 62 studies had assessed risk factors for death from COVID 28–89 ); 13 studies determined risk factors for severity (( 41,50,53–55,65,…”